Skip to content

BETTERLIFE PHARMA INC.

BETRF

CIK 0001464165

← back to feed
Revenue (TTM)
—
FY May 2025
Net Income (TTM)
−$8.29M
−7,447.6% YoY FY May 2025
EPS Diluted (TTM)
−$0.08
−10.0% YoY FY May 2025
Gross Margin
—
FY May 2025
Operating Margin
—
FY May 2025
Net Margin
—
FY May 2025
Free Cash Flow (TTM)
—
FY May 2025
Cash
$45.41K
FY May 2025
Total Debt
—
FY May 2025
Shares Outstanding
145.49M sh
FY May 2025

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings